Image 1
Levalbuterol Solution
Product Images NDC 0093-4148
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Levalbuterol (NDC 0093-4148). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure E.1 (Image 10)
Figure E.2 (Image 11)
Figure F (Image 12)
Figure G.1 (Image 13)
Figure G.2 (Image 14)
Levalbuterol Inhalation Solution Usp 0.31 mg/3 mL 24 Unit-dose Vials Carton, Part 1 Of 2 (Image 15)
This text describes a medication called Levalbuterol Inhalation Solution, which is sold in unit-dose vials. Each vial contains 0.31 mg of levalbuterol hydrochloride in an aqueous solution. The medication is intended for oral inhalation only and should be used as directed by a physician. The vials should be stored in a protective foil pouch, and once opened, must be used within one or two weeks, depending on whether or not they have been removed from the pouch. The medication should be discarded if the solution is not colorless. The product should be kept out of reach of children and protected from light and excessive heat. The text provides a National Drug Code (NDC) number for the product and suggests that pharmacists should detach the patient information and instructions for use from the package insert and dispense it with the product.*
Levalbuterol Inhalation Solution Usp 0.31 mg/3 mL 24 Unit-dose Vials Carton, Part 2 Of 2 (Image 16)
This is a description of a medication containing Levalbuterol Inhalation Solution. It comes in the form of 30 unit-dose vials (6 packs of 5 vials each), with each vial containing 0.31 mg/3 mL of the solution. The packaging includes a VARNISH FREE AREA and it is manufactured by Norton Healthcare Limited in England, for Teva Pharmaceuticals in the USA. The product is only for oral inhalation and not suitable for injection.*
Levalbuterol Inhalation Solution Usp 0.63 mg/3 mL 24 Unit-dose Vials Carton, Part 1 Of 2 (Image 17)
This text describes information about a medication called Levalbuterol Inhalation Solution USP, which is provided in individual unit-dose vials. Each vial contains 0.63 mg of Levalbuterol and is intended for oral inhalation use only. The solution does not contain preservatives and should be used only as directed by a physician. The vials should be kept in a protective foil pouch until use, with each individual unit-dose vial being used within one week of the pouch being opened. The package contains six pouches with five 3 mL vials in each (30-unit dose vials). Storage instructions are also provided.*
Levalbuterol Inhalation Solution Usp 0.63 mg/3 mL 24 Unit-dose Vials Carton, Part 2 Fo 2 (Image 18)
This is a product description for a medication called Levalbuterol Inhalation Solution USP. The medication comes in 6 pouches, each containing 5 unit-dose vials of 3 mL each, totaling to 30 vials. The vials are sterile and for oral inhalation only, and are not meant for injection. The medication is manufactured in England by Norton Healthcare Limited T/A IVAX Pharmaceuticals UK and is distributed in North Wales, PA 19454 by Teva Pharmaceuticals USA, Inc. The product is branded as Steri-Neb™ by Norton Healthcare Limited. The package includes the dimensions of the product which are 91.5 x 92 x 118.5mm. The text 'fijflfi' appears to be unreadable.*
Levalbuterol Inhalation Solution Usp 1.25 mg/3 mL 24 Unit-dose Vials Carton, Part 1 Of 2 (Image 19)
This is an information leaflet for Levalbuterol Inhalation Solution USP, contained in a unit-dose vial. Each vial contains 1.25 mg of levalbuterol as the hydrochloride salt in an aqueous solution. The solution does not contain any preservatives and is intended for oral inhalation only, not for injection. Vials should be used within two weeks if stored in the protective foil pouch and within one week if removed from the foil pouch. The pharmacist should detach "Patient Information/Instructions for Using Levalbuterol Inhalation Solution USP" from the package insert and dispense it with the product. The product should be stored at 20° to 25°C and protected from light and excessive heat. If the solution is not colorless, discard it. The NDC code for the product is 0093-4148-56.*
Image 2
Levalbuterol Inhalation Solution Usp 1.25 mg/3 mL 24 Unit-dose Vials Carton, Part 2 Of 2 (Image 20)
This is an inhalation solution product of Levalbuterol manufactured by Norton Healthcare Limited and sold by Teva Pharmaceuticals USA. It comes in 6 pouches containing 5 vials of 3 mL each, for a total of 30 vials that are meant for oral inhalation only. The product is labelled with its NDC code as well as manufacturing and trademark information. Its dimension is 91.5x92x118.5mm.*
Image 3
The text is not available.*
Image 4
Image 5
Image 6
This text is describing an image or diagram of a vial, indicating the shaded area which refers to the twisted-tab portion of the vial.*
Image 7
Image 8
Image 9
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
